Detalhe da pesquisa
1.
A phase I dose-escalation study of TAK-733, an investigational oral MEK inhibitor, in patients with advanced solid tumors.
Invest New Drugs
; 35(1): 47-58, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27650277
2.
Phase 1 study of the pan-RAF inhibitor tovorafenib in patients with advanced solid tumors followed by dose expansion in patients with metastatic melanoma.
Cancer Chemother Pharmacol
; 92(1): 15-28, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37219686
3.
SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study.
J Neuropathol Exp Neurol
; 62(6): 617-26, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12834106
4.
Safety and clinical activity of a combination therapy comprising two antibody-based targeting agents for the treatment of non-Hodgkin lymphoma: results of a phase I/II study evaluating the immunoconjugate inotuzumab ozogamicin with rituximab.
J Clin Oncol
; 31(5): 573-83, 2013 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-23295790